In this issue:
- Remote screening for asymptomatic AF
- FFR-guided complete vs culprit-only revascularisation in NSTEMI
- Digoxin vs beta-blocker in patients with AF and HF
- Intravenous iron therapy for patients with HF and iron deficiency
- Beta-blockers post MI in patients with normal LVEF
- Oral PCSK9 inhibitor enlicitide in patients with familial hypercholesterolaemia
- Risk of sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy
- Aspirin for primary prevention of ASCVD in older adults
- Secondary prevention education initiated in hospital for patients with CHD
- Evolocumab in patients without a previous MI or stroke
Please login below to download this issue (PDF)